Updates
Trials
Our Network
Events
Publications
Media library
Stories
Our Future: Ecraid

Updates
Trials
Our Network
Events
Publications
Media library
Stories
Our Future: Ecraid

Combacte

About COMBACTE
Private-public partnership
Join our network
Funding
Partners
COMBACTE Magazine
COMBACTE Video
COMBACTE Newsletter
COMBACTE and COVID-19
REMAP-CAP

Projects

COMBACTE-NET
COMBACTE-MAGNET
COMBACTE-CARE
COMBACTE-CDI
Networks
- CLIN-Net
- LAB-Net
- EPI-Net
- STAT-Net
Poster and Presentation Platform
Project Management Office

Contact

Feel free to mail us for more information and media inquiries at info@combacte.com

Twitter LinkedIn

Search for:

Collateral Treatment Effects in Pseudomonas Aeruginosa on Antibiotic Susceptibility

Collateral Treatment Effects in Pseudomonas Aeruginosa on Antibiotic Susceptibility

About Combacte

About
Partners

Contact

Contact
Join our network
Twitter LinkedIn

Colophon
Privacy
Disclaimer

COMBACTE-NET, COMBACTE-CARE, and COMBACTE-MAGNET receive support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° 115523 | 115620 | 115737 resources of which are composed of financial contribution from the European Union Seventh Framework Programme (FP7/2007-2013) and EFPIA companies in kind contribution. COMBACTE-CDI receives support from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement n° 777362 resources of which are composed of financial contribution from the European Union’s Horizon 2020 research and innovation programme, and EFPIA.